文献速递瓣膜外科冠心病外科心外重症与机械循环支持

二尖瓣手术治乳头肌断裂:STS数据库1342例结局

Mitral Valve Surgery for Papillary Muscle Rupture: Outcomes in 1342 Patients From The Society of Thoracic Surgeons Database.
PubMed 文献 · Ann Thorac Surg · 2020-05-04

基于STS国家数据库2011–2018年1342例缺血性乳头肌断裂行二尖瓣手术患者,多数为二尖瓣置换(79.8%)且急诊手术(52.0%),operative mortality为20.0%,STS预测死亡风险16.9%±15.4%;主要并发症发生率高,但多数患者存活。

要点

  • 缺血性乳头肌断裂行二尖瓣手术operative mortality达20.0%,STS预测风险16.9%±15.4%。
  • 二尖瓣置换占79.8%,急诊手术占52.0%,同期CABG占59.3%。
  • 术前机械循环辅助:IABP 56.9%、Impella 4.1%、ECMO 3.1%。

核心结论

  • 二尖瓣手术治疗缺血性乳头肌断裂的死亡率和并发症发生率高,但多数患者可存活度过手术。

研究设计与样本

  • 回顾性队列研究,使用STS国家数据库2011–2018年因缺血性乳头肌断裂行二尖瓣手术的1342例患者,含同期手术。

主要发现

  • 二尖瓣置换占79.8%(n=1071),急诊手术占52.0%(n=698),同期CABG占59.3%(n=796)。
  • 术前机械循环辅助包括IABP 56.9%(n=764)、Impella 4.1%(n=55)、ECMO 3.1%(n=41)。
  • STS预测死亡风险为16.9%±15.4%,operative mortality为20.0%。
  • 输血占70.7%(n=949);延长通气61.8%(n=829)、急性肾衰竭15.4%(n=206)、再手术10.2%(n=137)、卒中5.2%(n=70)。
  • operative mortality的多变量预测因素包括二尖瓣置换、高龄、低白蛋白、心源性休克、EF<25%和急诊抢救状态。

临床怎么用

  • 对缺血性乳头肌断裂患者,二尖瓣手术虽风险高但多数可存活,应结合预测因素评估手术决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prior reports of mitral valve surgery (MVS) for ischemic papillary muscle rupture (PMR) have been limited in patient numbers. This study evaluated national outcomes of MVS for PMR using The Society of Thoracic Surgeons (STS) National Database. METHODS: The study cohort was composed of patients undergoing MVS for ischemic PMR between 2011 and 2018 in the STS registry. Concomitant procedures were included. The primary outcome was operative mortality. Secondary outcomes included STS major morbidities. Multivariable logistic regression was employed for risk adjustment using clinically important variables as well as those predictive in univariate analysis. RESULTS: A total of 1342 patients underwent MVS for PMR during the study period. Most of these were mitral valve replacements (79.8%; n = 1071) and were performed emergently (52.0%; n = 698). Concomitant coronary artery bypass grafting was performed in 59.3% (n = 796). Mechanical circulatory assistance before MVS included intraaortic balloon pump (56.9%; n = 764), Impella pump (4.1%; n = 55), and extracorporeal membrane oxygenation (3.1%; n = 41). The STS predicted risk for mortality was 16.9% ± 15.4%. Operative mortality was 20.0%. Blood products were transfused in 70.7% (n = 949). Major morbidity rates included prolonged ventilation (61.8%; n = 829), acute renal failure (15.4%; n = 206), reoperation (10.2%; n = 137), and stroke (5.2%; n = 70). Multivariable predictors of operative mortality included mitral valve replacement, older age, lower albumin, cardiogenic shock, ejection fraction less than 25%, and emergent salvage status. CONCLUSIONS: These data provide a national overview of outcomes after MVS for PMR. Rates of mortality and morbidity are high, but most patients survive operative intervention in this high-risk and otherwise lethal condition.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kilic A, Sultan I, Chu D, et al. Mitral Valve Surgery for Papillary Muscle Rupture: Outcomes in 1342 Patients From The Society of Thoracic Surgeons Database. Ann Thorac Surg. 2020. PMID: 32376352. doi:10.1016/j.athoracsur.2020.03.097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。